Yolentha M. Slootweg

Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management

Yolentha M. Slootweg, Irene T.M. Lindenburg, Joke M. Koelewijn et al. · American Journal of Obstetrics and Gynecology · 2018 · 69 citations · Full text

Neonatology, Anti-kell-mediated Hemolytic Disease, Laboratory Hematology +12

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non‐D and non‐K‐alloimmunized pregnancies

Johanna Maria Koelewijn, Yolentha M. Slootweg, Claudia C. Folman et al. · Transfusion · 2019 · 36 citations · Full text

Risk factors for <scp>RhD</scp> immunisation in a high coverage prevention programme of antenatal and postnatal <scp>RhIg</scp>: a nationwide cohort study

Yolentha M. Slootweg, Carolien Zwiers, Joke M. Koelewijn et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2022 · 21 citations · Full text

Survey of prophylactic use of uterotonics in the third stage of labour in the Netherlands

Marrit Smit, Giel van Stralen, Ron Wolterbeek et al. · Midwifery · 2012 · 14 citations

Fertility, Preterm Labor, Maternal Complication +11